PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

96 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Ahmed, M. et al.: In vivo microbeam radiation therapy at a conventional small animal irradiator. Cancers 16:581 (2024)
2.
Bauer, L.* et al.: Cannabidiol (CBD) protects lung endothelial cells from irradiation-induced oxidative stress and inflammation in vitro and in vivo. Cancers 16:3589 (2024)
3.
Damirov, F.* et al.: Perioperative predictive factors for tumor regression and survival in non-Small cell lung cancer patients undergoing neoadjuvant treatment and lung resection. Cancers 16:2885 (2024)
4.
Muhtadi, R.* et al.: Liquid biopsy in whole blood for identification of gene expression patterns (mRNA and miRNA) associated with recurrence of glioblastoma WHO CNS grade 4. Cancers 16:2345 (2024)
5.
Nguyen, N.T.T.* et al.: The spectrum of CAR cellular effectors: Modes of action in anti-tumor immunity. Cancers 16:2608 (2024)
6.
Plaza-Díaz, J.* et al.: Effect of a novel food rich in miraculin on the oral microbiome of malnourished oncologic patients with dysgeusia. Cancers 16:3414 (2024)
7.
Santiago Franco, M. ; Raulefs, S. ; Schilling, D. ; Combs, S.E. & Schmid, T.E.: Impact of radiation on invasion and migration of glioma in vitro and in vivo. Cancers 16:3900 (2024)
8.
Zhao, X.* et al.: Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls. Cancers 130, 913–926 (2024)
9.
Andreu-Sanz, D.* & Kobold, S.: Role and potential of different T helper cell subsets in adoptive cell therapy. Cancers 15:18 (2023)
10.
Azimzadeh, O.* et al.: Late effects of chronic low dose rate total body irradiation on the heart proteome of ApoE-/- mice resemble premature cardiac ageing. Cancers 15:21 (2023)
11.
Burkart, S.* et al.: A novel subgroup of UCHL1-related cancers is associated with genomic instability and sensitivity to DNA-damaging treatment. Cancers 15:16 (2023)
12.
Diehl, C. et al.: Dose reduction to motor structures in adjuvant fractionated stereotactic radiotherapy of brain metastases: nTMS-derived DTI-based motor fiber tracking in treatment planning. Cancers 15:282 (2023)
13.
Diehl, C. et al.: Low-energy X-ray intraoperative radiation therapy (Lex-IORT) for resected brain metastases: A single-institution experience. Cancers 15:14 (2023)
14.
Diehl, C. et al.: Opportunities and alternatives of modern radiation oncology and surgery for the management of resectable brain metastases. Cancers 15:26 (2023)
15.
Foreman, S.C.* et al.: Development and Evaluation of MR-Based Radiogenomic Models to Differentiate Atypical Lipomatous Tumors from Lipomas. Cancers 15:14 (2023)
16.
Gong, H.* ; Xue, B.* ; Ru, J. ; Pei, G.* & Li, Y.*: Targeted therapy for EWS-FLI1 in ewing sarcoma. Cancers 15:21 (2023)
17.
Hansen, F.J.* et al.: Circulating monocytes serve as novel prognostic biomarker in pancreatic ductal adenocarcinoma patients. Cancers 15:13 (2023)
18.
Lin, J.* et al.: Cytoreduction of residual tumor burden is decisive for prolonged survival in patients with recurrent brain metastases-retrospective analysis of 219 patients. Cancers 15:13 (2023)
19.
Modena, D.* et al.: Identification of a Novel SSTR3 full agonist for the treatment of nonfunctioning pituitary adenomas. Cancers 15:19 (2023)
20.
Spella, M. et al.: Non-oncogene addiction of KRAS-mutant cancers to IL-1β via versican and mononuclear IKKβ. Cancers 15:23 (2023)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮